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Abstract The aim of the study was to examine bone
density and architecture with three diﬀerent measure-
ment methods in a sample of young women with anor-
exia nervosa (AN) and in an age-matched control group
of women. Three-dimensional periphery quantitative
computer tomography (3D-pQCT) at the ultradistal
radius, a new technology providing measures of cortical
and trabecular bone density and architecture, was per-
formed, as well as quantitative ultrasound (QUS) at the
heel, and dual energy X-ray absorptiometry (DXA) at
the spine and hip. Thirty-six women with AN aged 18–
30 years (mean duration of AN: 5.8 years) and 30 age-
matched women were assessed. Bone mineral density
measured by DXA at the spine and hip, and broadband
ultrasound attenuation measured by QUS at the heel
were signiﬁcantly lower in patients than controls. 3D-
pQCT demonstrated a highly signiﬁcant deﬁcit in the
absolute number of bone trabecules and a signiﬁcant
reduction of cortical thickness. Severity of underweight
was signiﬁcantly associated with bone deﬁcits at the hip
measured by DXA. 3D-pQCT revealed mostly deﬁcits of
cortical bone related with age of onset of eating disorder.
Using three diﬀerent methods to measure bone density
and bone structure at the hip, spine, heel and ultradistal
radius, signiﬁcant deﬁcits in bone mineral density both
in trabecular and cortical bone, as well in trabecular
structure could be demonstrated in the AN patients.
Keywords Anorexia nervosa Æ Cortical and trabecular
bone Æ DXA Æ Osteoporosis Æ pQCT Æ QUS
Introduction
The pathogenesis of bone deﬁcits in patients with an-
orexia nervosa (AN) appears to be multi-factorial. Low
body weight, inadequate calcium, vitamin D and protein
intake, as well as alteration of hormone regulation
(sexual hormones, cortisol and insulin-like growth factor
I system) seem to be related with decreased bone mineral
density (BMD) [1,2]. However, the exact pathophysiol-
ogy of bone deﬁcits in AN has still not been totally
clariﬁed.
The standard method for measuring bone density is
dual energy X-ray absorptiometry measurement (DXA).
Using this method at the vertebral body and femoral
neck, several studies of the recent decades reported that
ca. 50% of AN patients showed bone density measure-
ments that were more than 2 SD below those of healthy
age-matched controls [3,4,5,6]. Generally, DXA mea-
surement of the vertebral body is considered most
appropriate to follow trabecular bone deﬁcits, whereas
measurement of the femoral neck and proximal part of
the distal forearm is better to follow cortical bone deﬁ-
cits. However, the DXA measurement can neither suf-
ﬁciently diﬀerentiate between cortical and trabecular
bone [7,8], nor give details with respect to bone archi-
tecture.
The quantitative ultrasound (QUS), a fast and radi-
ation-free method, has also been applied in samples with
AN women [9,10]. It has been shown that QUS per-
formed at the heel can predict fracture risk at the hip
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and the spine as reliably as DXA [11] and that it dif-
ferentiates between bone of healthy controls and of AN
patients [9]. However, QUS generates global measures of
bone density and does not distinguish between diﬀerent
bone compartments or provide information about
architecture of the bone.
Recently, a new three-dimensional method was intro-
duced for the measurement of bone density and structure,
namely the three-dimensional peripheral quantitative
computer tomography (3D-pQCT). 3D-pQCT is a non-
invasivemethod that examines bonemicrostructure in the
peripheral bone, typically at the ultradistal radius [12,13].
So far, only one study has utilized this technology in AN
patients [9], showing only modest diﬀerences between
healthy controls and AN subjects. However, the machine
used in the study by Resch et al. diﬀerentiated between
two parameters only (trabecular area and total area of the
region of interest), thus examined neither cortical bone
nor any parameters of bone structure.
In the present study, we introduced the technology of
a new multislice 3D-pQCT machine [14] in the investi-
gation of bone density and bone structure of women
aﬀected by AN. Using a resolution of approximately
160–200 lm, this technology produces measurements of
ten diﬀerent parameters distinguishing between cortical
bone and trabecular bone and examining diﬀerent as-
pects of bone architecture (ratio of vertical rods and
horizontal plates). More speciﬁcally, the method mea-
sures six diﬀerent parameters of trabecular bone, three
of which provide details of volumetric trabecular bone
density (density of trabecular area of the bone, density
of the sub cortical area of trabecular bone, and density
of the central part of the trabecular bone), and three
provide details of trabecular bone structure (trabecular
number, trabecular separation, and trabecular thick-
ness). In addition, the method measures two parameters
of cortical bone (cortical bone density and absolute
thickness of cortical bone) and two parameters of the
overall bone (mean entire bone density and relative bone
volume as part of the total volume in percent).
In this cross-sectional study, we examined a group of
young female AN patients and compared them to age-
matched female controls using the well-established DXA
method, QUS methodology, and multislice 3D-pQCT
technology. In addition, the study was aimed at identi-
fying anamnestic and clinical characteristics of AN that
might be associated with bone deﬁciencies. Bone density
and bone structure of AN patients were examined for
associations with patient characteristics relating to type
of AN, duration of underweight, lifetime minimum BMI
and characteristics relating to patient behavior.
Materials and methods
Patient group (PG)
Between February 1999 and February 2000, a total of 36
women with AN according to the Diagnostic and Sta-
tistical Manual of Mental Disorders 4th edn [15], with
an age range of 18–30 years were recruited via the Eating
Disorder Unit (inpatients and outpatients) of the Uni-
versity Hospital of Zurich. Pregnant women were ex-
cluded from the study. Age, body mass index (BMI),
and age at menarche of the PG are described in Table 1.
All AN patients had a BMI <17.5 (diagnostic criterion
for AN) at the time of recruitment. However, during the
time period between the initial recruitment and the
physical examinations, some weight changes occurred so
that the BMI at the time of examination ranged from
13.1 to 17.9 kg/m2 (mean±SD: 16.0±1.3). The average
age at AN onset was 17.6 years (SD 3.2) and the average
duration of the disorder was 5.8 years (SD 3.5). The
mean duration of underweight (BMI <17.5) was 56
months (SD 37) and the mean minimum lifetime BMI
was 13.2 (SD 1.7). The mean duration since the last
an=29, 1 CG S did not recall age at menarche
bPG n=22, CG n=13, 4 Ss did not report sexual hormone intake
duration
cANCOVA with age as covariate
dn=31, 5 PG Ss with missing data
Table 1 Characteristics of patient and control group. Data are presented as mean±SD unless otherwise noted
Variable Anorexia nervosa
(n=36)
Control group
(n=30)
Statistic df P
Age, years 23.4±3.7 22.8±2.1 t=0.8 56.4 0.38
Body mass index, kg/m2 16.0±1.3 20.5±1.5 t=13.2 64 <0.0001
Age at menarche, years 13.2±1.2 13.3±1.5a t=0.5 63 0.59
Use of calcium products, % 38.9 6.7 v2=9.3 1 0.002
Vitamin D use, % 19.4 3.3 Fisher exact NA 0.063
Sexual hormone use, % 63.9 53.3 v2=0.8 1 0.39
Sexual hormone intake duration, months 41.5±42.4b 25.5±20.3b F=1.6c 1,32 0.22
Total physical activity, h/week 16.1±17.4 10.3±11.7 MWU Z=0.9 NA 0.40
Weight bearing activity, h/week 8.2±7.2 4.6±3.8 MWU Z=2.3 NA 0.021
Smoking, % 27.8 40 v2=1.1 1 0.29
Smoking, cigarettes/week 95.7±92 34.5±40.5 t=1.9 1,11.9 0.076
Alcohol use, % 13.9 23.3 v2=1.0 1 0.32
Hashish use, % 2.8 3.3 Fisher exact NA 1.00
Time since last period, months 24.3±25.5d – – – –
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period was 24 months (SD 26). There was no primary
amenorrhea in the patient group.
Twenty-two (61%) patients had AN of the restricting
type, and 14 (39%) AN of the binge-purge type.
According to DSM IV, the restricting subtype describes
a presentation in which weight loss is accomplished
primarily through dieting or fasting. In contrast, the
binge-eating/purging subtype is diagnosed when the
individual has regularly engaged in binge eating or
purging (or both). Purging behavior is characterized by
vomiting or the misuse of laxatives, diuretics, or enemas.
Patients of the restrictive type had a lower BMI
(mean±SD: 15.6±1.4) than patients of the binge-purge
type [mean±SD: 16.5±0.7, t(34)=2.3, P<0.05]. They
also had a shorter duration of AN (mean±SD:
4.8±3.5) than patients of the binge-purge type
[mean±SD: 7.5±2.9, t(34)=2.4, P<0.05]. The two
groups did not diﬀer in age, age at ﬁrst period, age at
eating disorder onset, and minimum lifetime BMI.
Control group (CG)
A total of 30 femalemedical andpsychology studentswere
recruited through university lectures for the control
group. Inclusion criteria were: age 18–30, no current or
lifetime eating disorder, no underweight (i.e. current BMI
>18) and no regular intake of medication (except oral
contraceptives), no bone or other general diseases. The
CGmean current age and mean age at time of ﬁrst period
did not diﬀer from the PG (see Table 1). The age range in
the CG was smaller (20–28) and current age variances of
the two groups were not homogenous (P<0.001).
Procedures and assessments
The diagnosis of AN was made according to DSM IV
[15] at the Psychiatric Department (section of eating
disorders) of the University Hospital Zurich. All par-
ticipants were examined by a rheumatologist. Partici-
pants completed a questionnaire including socio-
demographic data, the history of eating disorder, (un-
der)weight, and menstruation, the use of medication,
hormonal substitution or contraceptives, as well as the
intake of vitamin, mineral, or calcium products. The
questionnaire also included questions on participants’
movement patterns such as postural and non-postural
sports, and hours of sport per week.
Measurement of bone mineral density and bone
micro-architecture
All patients and controls were examined with the fol-
lowing imaging methods.
Dual energy X-ray absorptiometry (DXA) of the
lumbar spine (L2–L4), the total proximal hip area and the
non-dominant femoral neck was performed using an
Hologic QDR 4500 device (Hologic Corp., Inc., Wal-
tham, Mass., USA). Areal bone density was expressed in
g/cm2. In addition, all valueswere expressed asT-scores as
absolute numbers deﬁned 1994 by the World Health
Organization (WHO) (amount of standard deviations
below or above the mean bone density value of young
white Caucasian women at peak bone mass). The short-
term precision of the DXA measurement after reposition
(coeﬃcients of variation, CV) was 1% at the level of the
lumbar spine and 1.5%at the total proximal hip area. The
technical short-termprecision of theHologicQDR4500 is
0.34%.
Quantitative ultrasound (QUS) measurement was
performed at the level of the calcaneus with the dry QUS
system of the Hologic Sahara device using an oil-based
coupling gel (Hologic Corp.). The speed of sound (SOS)
was measured in m/s and the broadband ultrasound
attenuation (BUA) in dB/MHz. In addition, the quanti-
tative ultrasound index (QUI), which is an index auto-
matically calculated by the machine, was listed. The
stability of the system was regularly measured and con-
sidered to be good; the precision was 5% for BUA and
0.3% for SOS [16].
Multislice three-dimensional periphery quantitative
computer tomography (3D-pQCT) of the ultradistal ra-
dius of the non-dominant forearm using multislice pro-
totype three-dimensional quantitative computer
tomography (3D-pQCT) (Scanco Medical Bassersdorf
Switzerland) [17,18]. The measurement protocol included
acquisition of a three-dimensional stack of 60 high-res-
olution CT slices at the most distal end of the radius using
a total observation region of 10 mm. Slice thickness was
0.28 mm, pixel matrix 512·512 and pixel size 0.17 mm.
To obtain cubic voxels, the consecutive cross-sectional
slices were measured in steps of 0.17 mm in the axial
direction. Measuring parameters are deﬁned as follows:
D100: mean entire bone (cortical and trabecular)
density of the ultradistal part of the radius in
grams hydroxyapatite equivalence per cm3
(grHA/cm3).
Dcomp: bone density of the cortical part of the bone
(grHA/cm3).
C.Th: absolute thickness of cortical bone in mm.
Dtrab: density of the trabecular area of the bone
(grHA/cm3).
Dmeta: density of the sub cortical area of the trabec-
ular bone (grHA/cm3).
Dinn: density of the central part of trabecular bone
(grHA/cm3) (Dinn and Dmeta together cor-
respond the total trabecular bone).
BV/TV: relative bone volume as part of the total vol-
ume in percent.
Tb.N: absolute number of trabecules per mm area.
Tb.Th: mean thickness of bone trabecules in mm.
Tb.Sp: mean separation distance between trabecules in
mm.
The average short-term precision of the multislice
high-resolution 3D-pQCT after repositioning is 1.1%
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for Dtrab and 1.6% for structural parameters such as
TbN [17,18].
DXA and QUS were conducted at the Department of
Rheumatology, University Hospital Zurich, 3D-pQCT
at the Institute for Biomedical Engineering, University of
Zurich and Federal Institute of Technology (ETH). All
three exams were conducted in a time span of maximal 8
weeks. The study was approved by the Ethics Committee
of the Psychiatric Department of the University Hospital
Zurich. All participants gave written consent.
Statistical analysis
Group diﬀerences were determined by t-tests in the
case of normally distributed variables, Mann-Whitney
U-tests for ordinal variables, chi-square and Fisher’s
exact tests for nominal variables. Bone density param-
eters were tested for group diﬀerences by means of
ANCOVA with age as a covariate. Partial correlations
were conducted testing associations between AN-related
characteristics and bone parameters while controlling
for age. Because of non-normality, the variables ‘‘life-
time duration BMI <17.5’’ and ‘‘time since last period’’
were log-transformed before testing for partial correla-
tions. P<0.05 were considered statistically signiﬁcant.
Results
Comparison of patient and control group characteristics
(Table 1)
Signiﬁcantly more patients used calcium products as
dietary supplements than participants in the CG. Mar-
ginally more patients than controls used vitamin D. No
diﬀerences between the two groups were found regarding
the proportion of participants using sexual hormones
(contraceptives or hormonal substitution) or the duration
of hormone intake.While the total amount of all physical
activities, comprising occupational activities, house and
garden work, did not diﬀer between the two groups, pa-
tients reported a signiﬁcantly higher amount of postural
activities than controls. No diﬀerences were found be-
tween both groups regarding the consumption of tobacco,
alcohol, or hashish, but the PG smokers smoked mar-
ginally more cigarettes per week than the CG smokers.
Comparison of patient and control groups regarding
bone density and structure as measured by the three
methods
Dual energy X-ray absorptiometry (DXA)
The World Health Organization (WHO) has provided
guidelines for assessing osteoporosis and osteopenia in
postmenopausal women when using DXA technology.
The WHO criteria are commonly used in clinical
practice, even with younger patients. They are also
used to determine severity of bone deﬁciency in re-
search on eating disorder patients [19,20]. Thus, to al-
low comparisons with the literature and to provide
information on the clinical severity of bone deﬁciencies
in the study sample, we examined our data using the
WHO criteria.
According the WHO deﬁnitions of osteopenia (DXA
T-score £ )1.0 SD and >)2.5 SD) and osteoporosis
(DXA T-score £ )2.5 SD) the DXA examination of the
femur/hip yielded eight AN patients (22%) with normal
bone density, 23 (64%) with osteopenia and ﬁve (14%)
with osteoporosis. DXA measurements of the lumbar
spine identiﬁed six AN patients (17%) with normal bone
density, 17 (47%) with osteopenia and 13 (36%) with
osteoporosis. In the CG, DXA examination of the femur
yielded 27 women (90%) with normal bone density and
three women (10%) with osteopenia. Measurements of
the lumbar spine identiﬁed 22 control women (74%)
with normal bone density, seven (23%) with osteopenia
and one (3%) with osteoporosis. Using a combination of
the two localizations, only 11% (n=4) AN patients had
normal bone density in both localizations, whereas 50%
(n=18) had osteopenia in at least one of the two local-
izations (but no osteoporosis) and 39% (n=14) had
osteoporosis in either or both localizations. In the CG
67% (n=20) showed normal bone density in both
localizations, 30% (n=9) had osteopenia in either or
both localizations (but no osteoporosis) and 3% (n=1)
had osteoporosis in either or both localizations. Seven
women (19.4%) in the patient group and four women
(13.3%) in the control group reported a history of
fracture.
All DXA parameters showed highly signiﬁcant dif-
ferences between the two groups regarding the mea-
surements of hip (femoral neck and total proximal hip
area) and spine bone mineral density (see Table 2). The
DXA t-values of the PG were signiﬁcantly lower than 0,
indicating that bone density in all three locations was
lower than the expected mean of the reference popula-
tion (see Table 2). DXA t-values of the CG were com-
parable to population means for femoral neck, but were
marginally lower for total hip, and signiﬁcantly lower
for lumbar spine (Table 2).
Quantitative ultrasound (QUS)
In the QUS heel measurements only the BUA was sig-
niﬁcantly lower in AN patients than in the control,
whereas QUI and SOS were comparable between the
two groups (Table 2).
Three-dimensional peripheral quantitative computer
tomography (3D-pQCT)
The 3D-pQCT measurements of the ultradistal radius
yielded the most signiﬁcant diﬀerences between the
groups in the number of trabecules per mm (Tb.N) and
the interconnected average separation distance between
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trabecules (Tb.Sp). Furthermore, still signiﬁcant but
considerably smaller diﬀerences were found in the
average bone density of the entire bone diameter (cor-
tical and trabecular) (D100), the thickness of the bone
cortex (C.Th), the density of the total trabecular area
(Dtrab), the sub cortical trabecular bone area (Dmeta),
the inner area of trabecular bone (Dinn), and the relative
bone volume as part of the total volume in percent (BV/
TV) (Table 2).
Associations between AN-related characteristics and
parameters of bone density and structure
Comparing patients with restrictive AN and binge-purge
AN, no diﬀerences in any of the bone parameters as
measured by the three methods were found. Table 3 lists
the potential correlations of several AN-related charac-
teristics (minimum lifetime BMI, duration BMI <17.5,
age of AN onset and duration of amenorrhea) with the
parameters of the three methods (calculated within the
patient group). The minimum lifetime BMI showed the
highest signiﬁcant correlations with DEXA of the total
hip area, followed by the femoral neck. There was no
signiﬁcant correlation of lumbar spine with this
parameter and only a modest but signiﬁcant correlation
with all QUS measurements. Furthermore, duration of
underweight was also signiﬁcantly correlated in partic-
ular to the DXA measurement of the total hip area and
to a lesser degree but still signiﬁcant to DXA of the
femoral neck and spine, SOS and QUI at the heel and
C.Th, Tb.N by 3D-pQCT at the ultradistal radius. With
regard to the 3D-pQCT measurements Dcomp and C.Th
showed signiﬁcant correlations with duration of under-
weight and age of AN onset. Finally, D100 and Tb.N
evidenced only modestly signiﬁcant correlations with
duration of underweight and age of AN onset. An
analysis of covariance was conducted comparing women
who developed AN before completion of puberty (17
years of age) with women whose AN onset was after
completion of puberty with regard to DEXA, US and
3D-pQCT parameters while controlling for current age.
Women with an onset age before 17 (n=17) had sig-
niﬁcantly lower C.Th (EM=0.85, SE=0.04) and
Dcomp (EM=852.8, SE=20.3) values than women with
onset at 17 or older (n=19) [C.Th: EM=0.98, SE=0.04,
F(1,33)=4.3, P=0.045; D.Comp: EM=920.8,
SE=19.0, F(1,33)=5.2, P=0.030]. None of the other
bone parameters diﬀered between these two groups
(Table 3).
Discussion
In this cross-sectional study, three diﬀerent techniques,
DXA, QUS and 3D-pQCT, were used to determine bone
mineral density and structure in a group of female AN
patients and an age and sex-matched control group.
DEXA and QUS revealed that bone density in AN pa-
tients was signiﬁcantly lower than in controls.
Table 2 Bone density and structure in patients and control group as measured by the three methods
Anorexia nervosa (n=36) Control group (n=30) F(1,63)b P
Estimated mean±SE ta df=35 P Estimated
mean±SE
ta df=29 P
DXA
Femoral neck BMD 0.72±0.02 – – 0.88±0.02 – – 43.5 <0.0001
T-score femoral neck )1.21±0.16 8.6 <0.0001 0.30±0.17 1.7 0.11 42.5 <0.0001
Total hip BMD 0.76±0.02 – – 0.98±0.02 – – 71.0 <0.0001
T-score total hip )1.47±0.14 11.5 <0.0001 0.30±0.15 1.8 0.08 71.6 <0.0001
Lumbar spine BMD 0.86±0.02 – – 1.01±0.02 – – 31.3 <0.0001
T-score lumbar spine )1.92±0.16 12.3 <0.0001 )0.60±0.18 2.9 0.006 29.6 <0.0001
QUS calcaneus
QUI 108.4±3.3 – – 114.9±3.6 – – 1.8 0.19
BUA 71.5±2.6 – – 89.2±2.9 – – 20.9 <0.0001
SOS 1585.6±6.3 – – 1583.5±6.9 – – 0.0 0.83
3D-pQCT radius
D100 359.4±10.3 – – 397.7±11.3 – – 6.3 0.015
Dcomp 888.4±12.6 – – 908.4±13.8 – – 1.1 0.29
C.Th 0.92±0.03 – – 1.03±0.03 – – 7.3 0.009
Dtrab 173.4±7.0 – – 196.1±7.7 – – 4.7 0.033
Dmeta 217.4±6.8 – – 240.1±7.5 – – 5.0 0.028
Dinn 141.7±7.4 – – 164.3±8.1 – – 4.3 0.043
BV/TV 0.14±0.006 – – 0.16±0.006 – – 4.8 0.032
Tb.N 1.57±0.01 – – 1.66±0.01 – – 30.8 <0.0001
Tb.Th 0.09±0.003 – – 0.10±0.003 – – 1.6 0.21
Tb.Sp 0.55±0.007 – – 0.51±0.008 – – 16.3 0.0001
aOne-sample t-testing diﬀerence from 0
bANCOVA with age as covariate
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When combining the DEXA measurements at the
lumbar spine and the hip, nearly 40% of the AN
patients fulﬁlled the WHO deﬁnition of osteoporosis
(T-score £ )2.5). This proportion is comparable with
results of other studies [3,19,20]. Only 11% of the AN
patients had normal bone density; this ﬁnding under-
lines the severity of bone deﬁcits in young women
suﬀering from AN.
The DXA measurements showed highly signiﬁcant
diﬀerences between AN and controls in all three tested
localizations (femoral neck, total hip, lumbar spine). Of
the three QUS parameters measured at the heel, only
BUA revealed a signiﬁcant diﬀerence between AN pa-
tients and the control group. This pattern is consistent
with ﬁndings reported by others [9,10].
Based on the localization of aﬀected bone, the cur-
rent viewpoint is that AN causes deﬁcits both in can-
cellous and cortical bone [2,21]. The results of our study
support this view. They also provide some information
how these deﬁcits are represented in the bone microar-
chitecture. The multislice high resolution 3D-pQCT
technique of the ultradistal radius showed that AN pa-
tients had a signiﬁcantly lower number of trabecules per
mm (Tb.N) and a signiﬁcantly larger interconnected
average separation distance between trabecules (Tb.Sp)
than controls. Patients and controls did not diﬀer
regarding mean trabecular thickness (Tb.Th). These re-
sults suggest that trabecules require a minimum thick-
ness to subsist and that the nutritional deﬁciencies of
AN patients cause entire trabecules to disappear, or
prevent the development of trabecules, producing a
clinical picture in which trabecules are more widely
separated but not, or only slightly, reduced in thickness.
When conducting transiliac bone biopsies of patients
with non-traumatic vertebral compression fractures and
hip fractures without severe trauma, Parﬁtt et al. [22]
found comparable changes in the microarchitecture
supporting this mechanism of trabecular deﬁciency.
With regard to cortical bone, our study revealed that
AN patients had signiﬁcantly lower cortical thickness at
the ultradistal radius than controls. In addition, all
cortical parameters, the 3D-pQCT measurements of the
entire bone diameter (D100), the bone density of the
cortical part of the bone (Dcomp), and the absolute
thickness of the cortical bone (C.Th), were signiﬁcantly
associated with age of AN onset. As none of the tra-
becular measures showed such associations, our results
indicate that a younger age at onset of AN mostly af-
fects the development or maintenance of cortical bone,
speciﬁcally of the ultradistal radius.
Seemann et al. [21] observed that patients with onset
of AN before puberty had bone deﬁcits in vertebral and
femoral locations, whereas patients with adult onset
showed bone loss mostly in vertebral localizations. The
authors inferred that AN aﬀects diﬀerent regions at
diﬀerent ages depending on the stage of bone
growth and development. For instance, before puberty
appendicular growth is more rapid than axial, whereas
during puberty appendicular growth slows and axialT
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growth accelerates [21]. In our study, the minimum
lifetime body mass index (BMI), which represents the
severity of underweight since onset of AN, was associ-
ated with hip DXA measurements but not with spine
DXA. As the hip localization is principally representa-
tive of cortical bone, and the spine localization of tra-
becular bone, these results could suggest that the degree
of underweight has a greater eﬀect on the cortical than
the trabecular part of bone. The duration of under-
weight (months with BMI <17.5 kg/m2) was associated
with lower levels of bone density as measured by DXA
in all examined localizations, but especially for total hip.
Also, lower levels of 3D-pQCT cortical thickness (C.Th)
and lower number of trabecules (Tb.N) were linked with
the duration of underweight. The 3D-pQCT ﬁndings
indicate that duration of underweight aﬀects both, the
cortical and trabecular bone compartments.
Previous studies comparing the bone density be-
tween the two diﬀerent forms of AN, i.e. the restrictive
and the binge-purge type, have yielded inconsistent
ﬁndings [19,23,24,25]. Our study did not reveal any
diﬀerences between the two forms of AN in any of the
bone parameters measured by the three methods. Our
lack of ﬁndings is consistent with suggestions by Go-
ebel et al. that the degree of underweight is an
important predictor of low bone density, whereas other
behaviors like bingeing and purging seem to be of
relatively minor importance [25]. It should be noted,
too, that the discrimination between the two AN types
is based on behavioral symptoms (e.g. purging) that
frequently change during the course of the illness
[26,27]. Because the distinction between the two types is
based on current symptomatology, it may yield groups
that are not homogenous with regard to history of
restrictive or binge-purge behavior. This heterogeneity
is bound to mask diﬀerences in eﬀects that restric-
tive eating and binge-purging might have on bone
parameters.
Several limitations of the study are of note. While AN
patients and controls were generally comparable with
respect to demographic parameters and lifestyle char-
acteristics, the age range of the control group was
smaller and variances were not homogenous in the two
groups. However, patients and controls did not diﬀer
regarding mean age. In addition, the DXA t-values of
the control group were comparable to population means
for femoral neck, but were marginally lower for total
hip, and signiﬁcantly lower for lumbar spine. It is con-
ceivable that our control group was subject to a genetic
predisposition selection bias. Because of the currently
available technology it was not possible to examine the
same skeletal regions with the three methods used in this
study. Direct comparisons between the examined regions
are curtailed because of diﬀerences in bone characteris-
tics at the diﬀerent skeletal sites (axial/appendicular,
proximal/distal, bone region with and without postural
eﬀect). It is conceivable that future technology will
enable the examination of diﬀerent bone regions with
the same methodology.
In summary, we found signiﬁcant bone deﬁcits in AN
patients compared to controls in all examined skeletal
locations independent of the method used. In AN pa-
tients speciﬁc anamnestic characteristics were linked
with deﬁciencies in diﬀerent bone localizations in both
cortical and trabecular compartments. This is the ﬁrst
study to show the eﬀect of AN on cortical and trabec-
ular bone, not simply by assessing the localization of
deﬁcits, but by speciﬁcally examining the bone mic-
roarchitecture using the new technology of 3D-pQCT.
In conclusion, using diﬀerent techniques to assess bone
mineral density and bone structure, our results conﬁrm
the high prevalence and high degree of site-speciﬁc bone
deﬁciencies in young women with AN.
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